Serious, life-threatening, or fatal respiratory depression may occur with use of BUTRANS, especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper …

Consider an alternative initiation approach for patients unable to taper to 30 mg MEDD or with concern for/history of intolerable opioid withdrawal during buprenorphine initiation.

Dec 31, 2025 · BUTRANS is a transdermal system providing systemic delivery of buprenorphine, a mu opioid partial agonist analgesic, continuously for 7 days. The chemical name of buprenorphine is ...

Dec 17, 2024 · Find patient medical information for Buprenorphine transdermal (Butrans) on WebMD including its uses, side effects and safety, interactions, pictures, warnings, and user ratings

BUTRANS contains buprenorphine, a Schedule III controlled substance. As an opioid, BUTRANS exposes users to the risks of addiction, abuse, and misuse [see Drug Abuse and Dependence (9)].

Taking BUTRANS with other opioid medicines, benzodiazepines, alcohol, or other central nervous system depressants (including street drugs) can cause severe drowsiness, decreased awareness, …

Jan 11, 2024 · Butrans (Buprenorphine Transdermal) may treat, side effects, dosage, drug interactions, warnings, patient labeling, reviews, and related medications including drug comparison and health …

Jan 13, 2025 · Learn about buprenorphine patch (Butrans) usage and dosing. Read the latest news and reviews about the drug as well as potential side effects and popular alternatives.

Jan 16, 2025 · Butrans is an extended-release transdermal patch containing buprenorphine, an opioid medication that partially activates mu-opioid receptors while limiting many of the dangerous side …

What is Butrans (buprenorphine), and how does it work? Butrans (buprenorphine) is a prescription medicine used to treat the symptoms of Chronic Severe Pain. Butrans may be used alone or with …